Comparison of day 3 and day 5 thyroglobulin results after thyrogen injection in differentiated thyroid cancer patients.

about

Comparison of day 3 and day 5 thyroglobulin results after thyrogen injection in differentiated thyroid cancer patients.

Item

http://www.wikidata.org/entity/Q55076373

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh

2018年學術文章

@zh-hant

name

Comparison of day 3 and day 5 ...... iated thyroid cancer patients.

@en

Comparison of day 3 and day 5 ...... iated thyroid cancer patients.

@nl

type

Item

label

Comparison of day 3 and day 5 ...... iated thyroid cancer patients.

@en

Comparison of day 3 and day 5 ...... iated thyroid cancer patients.

@nl

prefLabel

Comparison of day 3 and day 5 ...... iated thyroid cancer patients.

@en

Comparison of day 3 and day 5 ...... iated thyroid cancer patients.

@nl

P1476

Comparison of day 3 and day 5 ...... tiated thyroid cancer patients

@en

P2093

Burcak Gunes

http://www.w3.org/2001/XMLSchema#string

Esra Hatipoglu

http://www.w3.org/2001/XMLSchema#string

Kerim Sönmezoğlu

http://www.w3.org/2001/XMLSchema#string

Lebriz Uslu

http://www.w3.org/2001/XMLSchema#string

Sait Sager

http://www.w3.org/2001/XMLSchema#string

P2860

2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer

Preparation with recombinant human thyroid-stimulating hormone for thyroid remnant ablation with 131I is associated with lowered radiotoxicity.

Potential use of recombinant human thyrotropin in the treatment of distant metastases in patients with differentiated thyroid cancer.

The effectiveness of recombinant human thyroid-stimulating hormone versus thyroid hormone withdrawal prior to radioiodine remnant ablation in thyroid cancer: a meta-analysis of randomized controlled trials

Thyroglobulin measurement using highly sensitive assays in patients with differentiated thyroid cancer: a clinical position paper

Genetic variants associated with serum thyroid stimulating hormone (TSH) levels in European Americans and African Americans from the eMERGE Network.

Increasing diagnosis of subclinical thyroid cancers leads to spurious improvements in survival rates

Impact of surgical treatment on outcomes for papillary thyroid cancer.

Radiation Safety in Nuclear Medicine Procedures.

Exposed medical staff: challenges, available tools, and opportunities for improvement.

P304

177-183

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/2042018818770108

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Sylvia L. Asa

P577

2018-04-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29854387

http://www.w3.org/2001/XMLSchema#string

P932

5956637

http://www.w3.org/2001/XMLSchema#string